HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: M400094-MCP200v1 3/12/1211    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fukada, K. Articles by Zhu, H. Search for Related Content PubMed PubMed Citation Articles by Fukada, K. Articles by Zhu, H. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 3:1211-1223, 2004.
© 2004 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

Mitochondrial Proteomic Analysis of a Cell Line Model of Familial Amyotrophic Lateral Sclerosis^*

Kei Fukada, Fujian Zhang, Alexis Vien, Neil R. Cashman^¶ and Haining Zhu^,,||

Department of Molecular and Cellular Biochemistry, College of Medicine
Graduate Center for Nutritional Sciences, University of Kentucky, Lexington, KY 40536
^¶ Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, M5S 3H2, Canada

Mutations in copper-zinc superoxide dismutase (SOD1) have been linked to a subset of familial amytrophic lateral sclerosis (fALS), a fatal neurodegenerative disease characterized by progressive motor neuron death. An increasing amount of evidence supports that mitochondrial dysfunction and apoptosis activation play a critical role in the fALS etiology, but little is known about the mechanisms by which SOD1 mutants cause the mitochondrial dysfunction and apoptosis. In this study, we use proteomic approaches to identify the mitochondrial proteins that are altered in the presence of a fALS-causing mutant G93A-SOD1. A comprehensive characterization of mitochondrial proteins from NSC34 cells, a motor neuron-like cell line, was achieved by two independent proteomic approaches. Four hundred seventy unique proteins were identified in the mitochondrial fraction collectively, 75 of which are newly discovered proteins that previously had only been reported at the cDNA level. Two-dimensional gel electrophoresis was subsequently used to analyze the differences between the mitochondrial proteomes of NSC34 cells expressing wild-type and G93A-SOD1. Nine and 36 protein spots displayed elevated and suppressed abundance respectively in G93A-SOD1-expressing cells. The 45 spots were identified by MS, and they include proteins involved in mitochondrial membrane transport, apoptosis, the respiratory chain, and molecular chaperones. In particular, alterations in the post-translational modifications of voltage-dependent anion channel 2 (VDAC2) were found, and its relevance to regulating mitochondrial membrane permeability and activation of apoptotic pathways is discussed. The potential role of other proteins in the mutant SOD1-mediated fALS is also discussed. This study has produced a short list of mitochondrial proteins that may hold the key to the mechanisms by which SOD1 mutants cause mitochondrial dysfunction and neuronal death. It has laid the foundation for further detailed functional studies to elucidate the role of particular mitochondrial proteins, such as VDAC2, in the pathogenesis of familial ALS.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Zhang, A.-L. Strom, K. Fukada, S. Lee, L. J. Hayward, and H. Zhu Interaction between Familial Amyotrophic Lateral Sclerosis (ALS)-linked SOD1 Mutants and the Dynein Complex J. Biol. Chem., June 1, 2007; 282(22): 16691 - 16699. [Abstract] [Full Text] [PDF]

				J. Gal, A.-L. Strom, R. Kilty, F. Zhang, and H. Zhu p62 Accumulates and Enhances Aggregate Formation in Model Systems of Familial Amyotrophic Lateral Sclerosis J. Biol. Chem., April 13, 2007; 282(15): 11068 - 11077. [Abstract] [Full Text] [PDF]

				T. D. Vo and B. O. Palsson Building the power house: recent advances in mitochondrial studies through proteomics and systems biology Am J Physiol Cell Physiol, January 1, 2007; 292(1): C164 - C177. [Abstract] [Full Text] [PDF]

				H. Zischka, R. J. Braun, E. P. Marantidis, D. Buringer, C. Bornhovd, S. M. Hauck, O. Demmer, C. J. Gloeckner, A. S. Reichert, F. Madeo, et al. Differential Analysis of Saccharomyces cerevisiae Mitochondria by Free Flow Electrophoresis Mol. Cell. Proteomics, November 1, 2006; 5(11): 2185 - 2200. [Abstract] [Full Text] [PDF]

				T. J. Lukas, W. W. Luo, H. Mao, N. Cole, and T. Siddique Informatics-assisted Protein Profiling in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis Mol. Cell. Proteomics, July 1, 2006; 5(7): 1233 - 1244. [Abstract] [Full Text] [PDF]

				C. A. Wood-Allum, S. C. Barber, J. Kirby, P. Heath, H. Holden, R. Mead, A. Higginbottom, S. Allen, T. Beaujeux, S. E. Alexson, et al. Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen Brain, July 1, 2006; 129(7): 1693 - 1709. [Abstract] [Full Text] [PDF]

				X. Lu and H. Zhu Tube-Gel Digestion: A Novel Proteomic Approach for High Throughput Analysis of Membrane Proteins Mol. Cell. Proteomics, December 1, 2005; 4(12): 1948 - 1958. [Abstract] [Full Text] [PDF]

				P J Shaw Molecular and cellular pathways of neurodegeneration in motor neurone disease J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1046 - 1057. [Abstract] [Full Text] [PDF]